Skip to main content

Advertisement

Log in

Neurodegenerative disease

Dementia risk variants — hunting needles in a haystack

  • News & Views
  • Published:

From Nature Reviews Neurology

View current issue Sign up to alerts

Genome-wide association studies have identified loci associated with neurodegenerative disease risk, but many of the implicated genetic variants are noncoding and their functional roles remain unclear. Using massively parallel reporter assays, CRISPR-based validation and genomic annotations, a new study functionally characterizes regulatory risk variants associated with Alzheimer disease and progressive supranuclear palsy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Ertekin-Taner, N. Gene expression endophenotypes: a novel approach for gene discovery in Alzheimer’s disease. Mol. Neurodegener. 6, 31 (2011).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Zou, F. et al. Brain expression genome-wide association study (eGWAS) identifies human disease-associated variants. PLoS Genet. 8, e1002707 (2012).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Allen, M. et al. Gene expression, methylation and neuropathology correlations at progressive supranuclear palsy risk loci. Acta Neuropathol. 132, 197–211 (2016).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Sieberts, S. K. et al. Large eQTL meta-analysis reveals differing patterns between cerebral cortical and cerebellar brain regions. Sci. Data 7, 340 (2020).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Ertekin-Taner, N., De Jager, P. L., Yu, L. & Bennett, D. A. Alternative approaches in gene discovery and characterization in Alzheimer’s disease. Curr. Genet. Med. Rep. 1, 39–51 (2013).

    Article  PubMed  PubMed Central  Google Scholar 

  6. Allen, M. et al. Divergent brain gene expression patterns associate with distinct cell-specific tau neuropathology traits in progressive supranuclear palsy. Acta Neuropathol. 136, 709–727 (2018).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Wan, Y.-W. et al. Meta-analysis of the Alzheimer’s disease human brain transcriptome and functional dissection in mouse models. Cell Rep. 32, 107908 (2020).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Wang, X. et al. Alzheimer’s disease and progressive supranuclear palsy share similar transcriptomic changes in distinct brain regions. J. Clin. Invest. 132, e149904 (2022).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Allen, M. et al. Conserved brain myelination networks are altered in Alzheimer’s and other neurodegenerative diseases. Alzheimers Dement. 14, 352–366 (2018).

    Article  PubMed  Google Scholar 

  10. Cooper, Y. A. et al. Functional regulatory variants implicate distinct transcriptional networks in dementia. Science 377, eabi8654 (2022).

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Nilüfer Ertekin-Taner.

Ethics declarations

Competing interests

The authors declare no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Oatman, S.R., Ertekin-Taner, N. Dementia risk variants — hunting needles in a haystack. Nat Rev Neurol 18, 705–706 (2022). https://doi.org/10.1038/s41582-022-00739-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41582-022-00739-1

  • Springer Nature Limited

Navigation